These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2307831)

  • 21. Severe hepatitis due to percutaneous diclofenac.
    Yerly G; Cereda JM
    Gastroenterol Clin Biol; 2008 Oct; 32(10):824-5. PubMed ID: 18818036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ipilimumab-associated Hepatitis: Clinicopathologic Characterization in a Series of 11 Cases.
    Johncilla M; Misdraji J; Pratt DS; Agoston AT; Lauwers GY; Srivastava A; Doyle LA
    Am J Surg Pathol; 2015 Aug; 39(8):1075-84. PubMed ID: 26034866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Droxicam-induced toxic hepatitis].
    Berenguer M; Pérez-Aguilar F; Gisbert C; Ferreres LA; Vera-Sempere FJ; Berenguer J
    Rev Esp Enferm Dig; 1996 Jan; 88(1):49-52. PubMed ID: 8616003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.
    Daly AK; Aithal GP; Leathart JB; Swainsbury RA; Dang TS; Day CP
    Gastroenterology; 2007 Jan; 132(1):272-81. PubMed ID: 17241877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [NSAID-induced hepatotoxicity: aceclofenac and diclofenac].
    Zaragoza Marcet A; Alfonso Moreno V; Roig Catalá E
    Rev Esp Enferm Dig; 1995 Jun; 87(6):472-5. PubMed ID: 7612373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].
    Jmelnitzky AC; Guidi M; Bologna A; Viola M; Soccini C; Barbero R; Belloni P; Apraiz M
    Acta Gastroenterol Latinoam; 2000; 30(2):77-84. PubMed ID: 10925723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of N-acetyl cysteine on oxidative stress and TNF-α gene expression in diclofenac-induced hepatotoxicity in rats.
    Nouri A; Heidarian E; Nikoukar M
    Toxicol Mech Methods; 2017 Oct; 27(8):561-567. PubMed ID: 28535741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoniazid-associated hepatitis. A study of five cases.
    Moss JD; Lewis JE; Knauer CM
    Am Rev Respir Dis; 1972 Dec; 106(6):849-56. PubMed ID: 4641220
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute alcoholic hepatitis in Singapore: a prospective clinicopathological study of 50 cases. 2. Haematological, biochemical, and histological investigations.
    Fung WP; Tan KK
    Med J Aust; 1973 Jun; 1(26):1284-9. PubMed ID: 4728364
    [No Abstract]   [Full Text] [Related]  

  • 30. [Liver damage caused by sensitivity to anti-inflammatory agents].
    Bogić M; Sojić J; Balaban J; Boricić I; Jesić R
    Srp Arh Celok Lek; 1997; 125(9-10):291-4. PubMed ID: 9340801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection from diclofenac-induced liver injury by Yulangsan polysaccharide in a mouse model.
    Huang J; Nguyen V; Tang X; Wei J; Lin X; Lai Z; Doan V; Xie Q; Huang R
    J Ethnopharmacol; 2016 Dec; 193():207-213. PubMed ID: 27497634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pantoprazole-induced autoimmune chronic hepatitis.
    Meunier L; Ursic-Bedoya J; Pageaux GP; Larrey D
    Liver Int; 2018 Jun; 38(6):995-999. PubMed ID: 29532602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nimesulide-induced hepatitis and acute liver failure.
    Weiss P; Mouallem M; Bruck R; Hassin D; Tanay A; Brickman CM; Farfel Z; Bar-Meir S
    Isr Med Assoc J; 1999 Oct; 1(2):89-91. PubMed ID: 10731303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity.
    Aithal GP; Ramsay L; Daly AK; Sonchit N; Leathart JB; Alexander G; Kenna JG; Caldwell J; Day CP
    Hepatology; 2004 May; 39(5):1430-40. PubMed ID: 15122773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of differential gene expression profiles on diclofenac-induced acute mouse liver injury and recovery.
    Chung H; Kim HJ; Jang KS; Kim M; Yang J; Kim JH; Lee YS; Kong G
    Toxicol Lett; 2006 Sep; 166(1):77-87. PubMed ID: 16859844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cholestatic hepatitis and acute kidney insufficiency during treatment with diclofenac].
    Hovette P; Touze JE; Debonne JM; Delmarre B; Rogier C; Schmoor P; Aubry P
    Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):257-8. PubMed ID: 2619253
    [No Abstract]   [Full Text] [Related]  

  • 37. The natural history of histologically proved drug induced liver disease.
    Aithal PG; Day CP
    Gut; 1999 May; 44(5):731-5. PubMed ID: 10205214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recovery from diclofenac-induced hypersensitive fulminant hepatitis and prostaglandins.
    Ohana M; Hajiro K; Takakuwa H; Okazaki K
    Dig Dis Sci; 1997 Oct; 42(10):2031-2. PubMed ID: 9365130
    [No Abstract]   [Full Text] [Related]  

  • 39. Liver injury from nonsteroidal anti-inflammatory drugs in the United States.
    Schmeltzer PA; Kosinski AS; Kleiner DE; Hoofnagle JH; Stolz A; Fontana RJ; Russo MW;
    Liver Int; 2016 Apr; 36(4):603-9. PubMed ID: 26601797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diclofenac sodium in osteoarthritis. Is there risk of hepatotoxicity? A systematic review].
    Matveev AV; Koniaeva EI
    Eksp Klin Gastroenterol; 2010; (10):93-100. PubMed ID: 21434381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.